Hao Tian - Third Military Medical University

基本信息

浏览量：0

职业迁徙

个人简介

Department of Breast & Thyroid surgery, Southwest Hospital

研究兴趣

论文共 25 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Tumor-Derived Extracellular Vesicles Enable Tumor Tropism Chemo-Genetherapy for Local Immune Activation in Triple-Negative Breast Cancer

Zaihui Peng, Tingting Zhao, Pingping Gao,Guozhi Zhang, Xiujuan Wu,Hao Tian, Man Qu, Xuanni Tan,Yi Zhang, Xiang Zhao,Xiaowei Qi

ACS NANO (2024)

引用0浏览0WOS引用

Two Hematological Markers Predicting the Efficacy and Prognosis of Neoadjuvant Chemotherapy Using Lobaplatin Against Triple-Negative Breast Cancer

Cheng Wang,Qiyun Shi,Guozhi Zhang,Xiujuan Wu,Wenting Yan,Andi Wan,Siyi Xiong,Long Yuan,Hao Tian,Dandan Ma,Jun Jiang,Xiaowei Qi,Yi Zhang

ONCOLOGIST (2024)

引用0浏览0WOS引用

Mechanism Study on Fig Exosome-Like Nanoparticles Inhibiting the Progression of Bone Metastasis in Breast Cancer

Dandan Wang,Hao Tian,Jin Qian,Tingting Zhao,Na Sun, Zifan Mei,Zaihui Peng,Yi Zhang,Xia Kang,Xiaowei Qi

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

引用0浏览0引用

Tumor Mutation Burden and PIK3CA Mutations Are Associated with Pathological Complete Response in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Patients Receiving Pyrotinib Combined with Trastuzumab Neoadjuvant Treatment

Qiyun Shi,Hao Tian,Dandan Ma,Juncheng Xuhong,Jia Ge,Feng Liu,Yang Lan,Peng Tang,Yan Liang,Li Chen,Linjun Fan,Yi Zhang,Tao Luo,Xiuwu Bian,Jun Jiang,Xiaowei Qi

JOURNAL OF CLINICAL ONCOLOGY（2024）

引用1浏览0引用

Taxane Combined with Lobaplatin or Anthracycline for Neoadjuvant Chemotherapy of Triple-Negative Breast Cancer: a Randomized, Controlled, Phase II Study

Cheng Wang,Long Yuan,Xiujuan Wu, Yan Wang,Hao Tian,Guozhi Zhang,Andi Wan,Siyi Xiong, Chengfang Wang, Yuqin Zhou,Dandan Ma,Yangqiu Bao,Man Qu,Jun Jiang,Yi Zhang,Xiaowei Qi

BMC Medicineno. 1 (2024): 1-10

引用0浏览0WOS引用

Safety and Efficacy of Anlotinib Combined with Taxane and Lobaplatin in Neoadjuvant Treatment of Clinical Stage II/III Triple-Negative Breast Cancer in China (the Neoaltal Trial): a Single-Arm, Phase 2 Trial

Yan Liang,Jing Liu,Jia Ge,Qiyun Shi,Guozhi Zhang,Andi Wan,Tao Luo,Hao Tian,Linjun Fan,Shushu Wang,Li Chen,Peng Tang,Kai Zhu,Jun Jiang,Xiuwu Bian,Yi Zhang,Xiaowei Qi

ECLINICALMEDICINE (2024)

引用0浏览0WOS引用

Targeted Multimodal Synergistic Therapy of Drug-Resistant HER2-positive Breast Cancer by Pyrotinib-Icg Self-Assembled Nanoparticles

Juncheng Xuhong, Nisha Wu,Qiyun Shi,Hao Tian,Zaihui Peng,Jun Jiang,Jing Zhang, Xiaowei Qi

AMERICAN JOURNAL OF CANCER RESEARCHno. 8 (2024)

引用0浏览0WOS引用

Abstract P5-02-52: Predictive and prognosis value of PIK3CA mutations in HER2-positive breast cancer treated with tyrosine kinase inhibitors (TKIs): a systemic review and meta-analysis

Qiyun Shi,Juncheng Xuhong,Hao Tian,Yi Zhang,Jun Jiang,Xiaowei Qi

Cancer Research（2023）

引用0浏览0引用

Investigating the role of FADS family members in breast cancer based on bioinformatic analysis and experimental validation

Tingting Zhao,Pingping Gao,Yanling Li,Hao Tian,Dandan Ma,Na Sun,Ceshi Chen,Yi Zhang,Xiaowei Qi

Frontiers in Immunology（2023）

引用1浏览0WOS引用

High Risks Adverse Events Associated with Trastuzumab Emtansine and Trastuzumab Deruxtecan for the Treatment of HER2-positive/mutated Malignancies: a Pharmacovigilance Study Based on the FAERS Database

Pan Ma,Hao Tian,Qiuling Shi,Ruixiang Liu,Yi Zhang,Xiaowei Qi,Yongchuan Chen

EXPERT OPINION ON DRUG SAFETY（2023）

引用1浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn